KYOCERA to Showcase Ceramics-Based Medical Technologies at MD&M West Expo, Feb. 11-13 in Anaheim

The new decade is bringing a radical transformation of healthcare based on Information and Communication Technology (ICT), particularly in developing regions. One example is the challenge to develop an affordable, reliable device that can quickly diagnose HIV, tuberculosis, malaria and other diseases, based on samples of blood, saliva and/or sputum, for use by rural clinics that may have electricity only a few hours per day. Kyocera’s proprietary Alumina-Sapphire microchemical chip is inspired in part by this challenge. It is designed for use in blood, saliva and sputum analysis; clinical tests; genome analysis and other diagnostic solutions. Since its direct bonding technology requires no separate bonding material, Kyocera’s proprietary solution enables a stronger connection; higher heat resistance; superior chemical resistance; and greatly reduced risk of error from substance/particle contamination — bringing the promise of e-medicine closer to underserved populations in need.

In many other examples, Kyocera’s Fine Ceramics can be found in solutions for genetic sequencing, blood separators, X-ray machines, pacemakers, cardiac monitors, neuromodulation devices, surgical tools, drug testing and orthopedic joint replacement systems. Many of these products will be on display at Kyocera’s MDM West booth, showcasing the latest technologies — from metallized ceramics for implantable devices, to zirconia hypodermic needles featuring an astounding internal-diameter dimensional precision plus-or-minus a single micron.

Click to learn more about Kyocera’s medical solutions. To schedule a dedicated booth appointment, please email fcsales@kyocera.com.